Skip to Content

ZA-37 150 mg (Venlafaxine Extended Release 150 mg)

Pill imprint ZA-37 150 mg has been identified as Venlafaxine hydrochloride extended release 150 mg.

Venlafaxine is used in the treatment of major depressive disorder; hot flashes; anxiety and stress; anxiety; depression (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Venlafaxine hydrochloride extended release 150 mg ZA-37 150 mg
Venlafaxine hydrochloride extended release 150 mg ZA-37 150 mg
Venlafaxine hydrochloride extended release
Imprint:
ZA-37 150 mg
Strength:
150 mg
Color:
Orange & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Zydus Pharmaceuticals USA Inc.
National Drug Code (NDC):
68382-0036
Inactive Ingredients:
silicon dioxide
cetostearyl alcohol
gelatin
hypromelloses
microcrystalline cellulose
ethyl acrylate - methyl methacrylate copolymer
sodium lauryl sulfate
magnesium silicate
titanium dioxide
ferric oxide red
ferrosoferric oxide

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide